301 related articles for article (PubMed ID: 16819286)
1. Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cells.
Kim SS; Lim SH; Cho SW; Gwak SJ; Hong YS; Chang BC; Park MH; Song KW; Choi CY; Kim BS
Exp Mol Med; 2006 Jun; 38(3):273-83. PubMed ID: 16819286
[TBL] [Abstract][Full Text] [Related]
2. Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves.
Gulbins H; Goldemund A; Anderson I; Haas U; Uhlig A; Meiser B; Reichart B
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):592-601. PubMed ID: 12658201
[TBL] [Abstract][Full Text] [Related]
3. Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating: a new technology for cardiovascular tissue engineering.
Guldner NW; Jasmund I; Zimmermann H; Heinlein M; Girndt B; Meier V; Flüss F; Rohde D; Gebert A; Sievers HH
Circulation; 2009 Mar; 119(12):1653-60. PubMed ID: 19289635
[TBL] [Abstract][Full Text] [Related]
4. Tissue engineering of heart valves in vivo using bone marrow-derived cells.
Kim SS; Lim SH; Hong YS; Cho SW; Ryu JH; Chang BC; Choi CY; Kim BS
Artif Organs; 2006 Jul; 30(7):554-7. PubMed ID: 16836737
[TBL] [Abstract][Full Text] [Related]
5. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
6. Successful endothelialization of porcine glutaraldehyde-fixed aortic valves in a heterotopic sheep model.
Gulbins H; Pritisanac A; Pieper K; Goldemund A; Meiser BM; Reichart B; Daebritz S
Ann Thorac Surg; 2006 Apr; 81(4):1472-9. PubMed ID: 16564295
[TBL] [Abstract][Full Text] [Related]
7. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
[TBL] [Abstract][Full Text] [Related]
8. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
9. Histological evaluation of tissue-engineered heart valves implanted in the juvenile sheep model: is there a need for in-vitro seeding?
Dohmen PM; da Costa F; Yoshi S; Lopes SV; da Souza FP; Vilani R; Wouk AF; da Costa M; Konertz W
J Heart Valve Dis; 2006 Nov; 15(6):823-9. PubMed ID: 17152791
[TBL] [Abstract][Full Text] [Related]
10. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
11. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes.
Baguneid M; Murray D; Salacinski HJ; Fuller B; Hamilton G; Walker M; Seifalian AM
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):151-7. PubMed ID: 15032735
[TBL] [Abstract][Full Text] [Related]
12. Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: a new technique to improve biologic heart valve prosthesis durability?
Guldner NW; Bastian F; Weigel G; Zimmermann H; Maleika M; Scharfschwerdt M; Rohde D; Sievers HH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1152-9. PubMed ID: 22153860
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of heart valve scaffold and cell seeding].
Long L; Wu C; Pan L; Qi X; Hong T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):610-3. PubMed ID: 15357443
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix.
Wilcox HE; Korossis SA; Booth C; Watterson KG; Kearney JN; Fisher J; Ingham E
J Heart Valve Dis; 2005 Mar; 14(2):228-36; discussion 236-7. PubMed ID: 15792184
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of xenogeneic heart valve material].
Shi KH; Zhang X; Zhang JF
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Nov; 17(6):496-500. PubMed ID: 14663952
[TBL] [Abstract][Full Text] [Related]
16. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
18. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
Weber B; Zeisberger SM; Hoerstrup SP
Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
[TBL] [Abstract][Full Text] [Related]
19. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E
J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063
[TBL] [Abstract][Full Text] [Related]
20. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold.
Cho SW; Jeon O; Lim JE; Gwak SJ; Kim SS; Choi CY; Kim DI; Kim BS
J Vasc Surg; 2006 Dec; 44(6):1329-40. PubMed ID: 17145438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
